Cleared Traditional

K133073 - CAIR DRIVE

K133073 is an FDA 510(k) clearance for CAIR DRIVE, manufactured by Cair Lgl. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 171-day FDA review.

K133073 · Cair Lgl · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
171d
Days
Class 2
Risk

K133073 is an FDA 510(k) clearance for the CAIR DRIVE, NEUTRACLEAR. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Cair Lgl (New York, US). The FDA issued a Cleared decision on March 20, 2014 after a review of 171 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Cair Lgl devices

FDA 510(k) Submission Details - K133073

510(k) Number K133073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2013
Decision Date March 20, 2014
Days to Decision 171 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 129d · This submission: 171d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 533
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K133073.
SOLUTION SET/EXTENSION SET
K142011 · Baxter Healthcare Corporation · Aug 2014
CARESITE LUER ACCESS DEVICE
K140311 · B.Braun Medical, Inc. · May 2014
MAXZERO EXTENSION SET WITH NEEDLESS CONNECTOR
K140831 · Care Fusion · Apr 2014
SURFLO WINGED INFUSION SET WITH FILTER & NEEDLE PROTECTION (SURSHIELD)
K133894 · Terumo Europe N.V. · Mar 2014
SURFLO WINGED INFUSION SET WITH NEEDLE PROTECTION (SURSHIELD)
K133867 · Terumo Europe N.V. · Feb 2014
MEDCOMP POWER INJECTABLE SAFETY HUBER NEEDLE
K132880 · Medical Components, Inc. · Jan 2014